Investing.com - Neogen (NASDAQ: NEOG) reported fourth quarter EPS of $0.10, $0.12 better than the analyst estimate of $-0.02. Revenue for the quarter came in at $236.8M versus the consensus estimate of $224.75M.
Guidance
Neogen sees FY 2025 revenue of $925.00M-$955.00M versus the analyst consensus of $937.50M.
Neogen's stock price closed at $17.30. It is up 38.96% in the last 3 months and down -25.40% in the last 12 months.
Neogen saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Neogen's stock price’s past reactions to earnings here.
According to InvestingPro, Neogen's Financial Health score is "good performance".
Check out Neogen's recent earnings performance, and Neogen's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar